Telcon RF Pharmaceutical Inc banner
T

Telcon RF Pharmaceutical Inc
KOSDAQ:200230

Watchlist Manager
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Watchlist
Price: 774 KRW 2.11% Market Closed
Market Cap: ₩53B

Telcon RF Pharmaceutical Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Telcon RF Pharmaceutical Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
T
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Research & Development
-₩773m
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
8%
D
DreamTech Co Ltd
KRX:192650
Research & Development
-₩29.8B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
K
KH Electron Co Ltd
KOSDAQ:111870
Research & Development
-₩487.8m
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
14%
P
Pavonine Co Ltd
KOSDAQ:177830
Research & Development
-₩1.1B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
-6%
P
PJ Electronics Co Ltd
KOSDAQ:006140
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Telcon RF Pharmaceutical Inc
Glance View

TELCON RF PHARMACEUTICAL.Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-24. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.

Telcon RF Pharmaceutical Inc Intrinsic Value
HIDDEN
Show

See Also

What is Telcon RF Pharmaceutical Inc's Research & Development?
Research & Development
-773m KRW

Based on the financial report for Sep 30, 2025, Telcon RF Pharmaceutical Inc's Research & Development amounts to -773m KRW.

What is Telcon RF Pharmaceutical Inc's Research & Development growth rate?
Research & Development CAGR 10Y
8%

Over the last year, the Research & Development growth was -15%. The average annual Research & Development growth rates for Telcon RF Pharmaceutical Inc have been 19% over the past three years , 15% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett